https://investors.abeonatherapeutics.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_798efd313b61071fa19d384f9817a343/abeonatherapeutics/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://investors.abeonatherapeutics.com/news-events/press-releases/detail/356/abeona-therapeutics-congratulates-ultragenyx-on-u-s-fda-approval-of-fayuvi-gene-therapy-for-sanfilippo-syndrome-type-a-mps-iiia Fri, 18 Sep 26 07:30:00 -0400 https://investors.abeonatherapeutics.com/news-events/press-releases/detail/356/abeona-therapeutics-congratulates-ultragenyx-on-u-s-fda-approval-of-fayuvi-gene-therapy-for-sanfilippo-syndrome-type-a-mps-iiia https://investors.abeonatherapeutics.com/news-events/press-releases/detail/355/abeona-therapeutics-announces-activation-of-university-of-florida-health-as-newest-qualified-treatment-center-for-zevaskyn Wed, 16 Sep 26 07:30:00 -0400 https://investors.abeonatherapeutics.com/news-events/press-releases/detail/355/abeona-therapeutics-announces-activation-of-university-of-florida-health-as-newest-qualified-treatment-center-for-zevaskyn https://investors.abeonatherapeutics.com/news-events/press-releases/detail/354/abeona-therapeutics-announces-participation-in-upcoming-investor-conferences Wed, 02 Sep 26 07:30:00 -0400 https://investors.abeonatherapeutics.com/news-events/press-releases/detail/354/abeona-therapeutics-announces-participation-in-upcoming-investor-conferences https://investors.abeonatherapeutics.com/news-events/press-releases/detail/353/abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listing-rule-5635c4 Tue, 01 Sep 26 07:30:00 -0400 https://investors.abeonatherapeutics.com/news-events/press-releases/detail/353/abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listing-rule-5635c4 https://investors.abeonatherapeutics.com/news-events/press-releases/detail/352/abeona-therapeutics-reports-second-quarter-2026-results-and-provides-business-update Thu, 13 Aug 26 07:30:00 -0400 https://investors.abeonatherapeutics.com/news-events/press-releases/detail/352/abeona-therapeutics-reports-second-quarter-2026-results-and-provides-business-update https://investors.abeonatherapeutics.com/news-events/press-releases/detail/351/abeona-therapeutics-to-host-second-quarter-2026-financial-results-conference-call-on-august-13-2026 Thu, 06 Aug 26 07:30:00 -0400 https://investors.abeonatherapeutics.com/news-events/press-releases/detail/351/abeona-therapeutics-to-host-second-quarter-2026-financial-results-conference-call-on-august-13-2026 https://investors.abeonatherapeutics.com/news-events/press-releases/detail/350/cms-grants-new-technology-add-on-payment-ntap-status-for-zevaskyn Tue, 04 Aug 26 07:30:00 -0400 https://investors.abeonatherapeutics.com/news-events/press-releases/detail/350/cms-grants-new-technology-add-on-payment-ntap-status-for-zevaskyn https://investors.abeonatherapeutics.com/news-events/press-releases/detail/349/abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listing-rule-5635c4 Mon, 03 Aug 26 07:30:00 -0400 https://investors.abeonatherapeutics.com/news-events/press-releases/detail/349/abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listing-rule-5635c4 https://investors.abeonatherapeutics.com/news-events/press-releases/detail/348/cincinnati-childrens-activated-as-the-seventh-qualified-treatment-center-for-zevaskyn Tue, 21 Jul 26 07:30:00 -0400 https://investors.abeonatherapeutics.com/news-events/press-releases/detail/348/cincinnati-childrens-activated-as-the-seventh-qualified-treatment-center-for-zevaskyn https://investors.abeonatherapeutics.com/news-events/press-releases/detail/347/abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listing-rule-5635c4 Wed, 01 Jul 26 07:30:00 -0400 https://investors.abeonatherapeutics.com/news-events/press-releases/detail/347/abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listing-rule-5635c4